AnaptysBio, Inc.
ANABNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $1.75B
- P/E (TTM)
- 8.96
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $30.27$73.30
- Volume (live)
- -
- Avg. volume (3M)
- 564.18K
AnaptysBio (ANAB) Stock Price & Financial Analysis
AnaptysBio Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $47.05 - $48.89 |
|---|---|
| 52-Week High | $73.30 |
| 52-Week Low | $30.27 |
| Open | $48.19 |
| Volume (last close) | 467.47K |
| Average Volume (3M) | 564.18K |
| Revenue (TTM) | 188.78M |
|---|---|
| Net Income (TTM) | 195.72M |
| Free Cash Flow (TTM) | 18.07M |
| EPS (TTM) | $6.26 |
| Profit Margin | 103.68% |
| Operating Margin | 70.94% |
| Return on Equity (ROE) | 1849.06% |
| Debt to Equity | 25.47 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 1.75B |
|---|---|
| Shares Outstanding | 35.98M |
| P/E Ratio (TTM) | 8.96 |
| Price to Sales (P/S) | 9.29 |
| Price to Book (P/B) | 165.62 |
| EV/EBITDA | 27.45 |
| 50-Day MA | $53.23 |
|---|---|
| 200-Day MA | $56.38 |
| 1-Year Change | +41.47% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
AnaptysBio at a Glance
As of the Oct 23, 2026 close, AnaptysBio (ANAB) has a market capitalization of $1.75B. The stock trades at 9.0× trailing earnings and 9.3× sales. Over the trailing twelve months it earned $195.72M on revenue of $188.78M (a 103.7% profit margin) and generated $18.07M of free cash flow. Revenue grew 27.0% year over year.
As of its latest reported balance sheet, it holds $133.83M in cash and securities against $269.59M of debt, a net debt position of $135.76M.
AnaptysBio does not currently pay a dividend.
The share price is up 41.5% over the past year. At $48.73 (the Oct 23, 2026 close) it sits within its 52-week range of $30.27 to $73.30, below its 200-day moving average of $56.38.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $77.40, 58.8% above the Oct 23, 2026 close.
Frequently Asked Questions About AnaptysBio
What is the current stock price for ANAB?
As of the Oct 23, 2026 close, ANAB stock trades at $48.73. The 52-week range is $30.27–$73.30, with a day range of $47.05–$48.89.
What is the P/E ratio for ANAB?
As of the Oct 23, 2026 close, AnaptysBio's trailing twelve-month (TTM) P/E ratio is 9.0, meaning investors pay $9.0 for every $1 of annual earnings. AnaptysBio operates in the Healthcare sector.
Does ANAB pay dividends?
AnaptysBio does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for ANAB?
Based on ratings from 6 professional analysts over the last 90 days, the consensus for ANAB is Buy. The average 12-month price target is $77.40, a 58.8% upside from the Oct 23, 2026 close of $48.73.
What is the market cap of ANAB?
As of the Oct 23, 2026 close, AnaptysBio's market capitalization is $1.75B, classifying it as a small-cap company. AnaptysBio operates in the Healthcare sector within the Biotechnology industry.